CClinicalTrials.gg
CompletedNCT06935318Updated Apr 20, 2025

Effects of High Functional Resistance Training Program on Arterial Stiffness

An interventional study of Exercise and Control in Training Study, sponsored by Salisbury University. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-20.

Sponsored by Salisbury University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 years 7 months after the study started (first participant enrolled Aug 2020, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Non-randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Study examined the effects of CrossFit training on blood vessels. The results indicate long term CrossFit training does not harm blood vessel function.

Read the detailed description

Arterial stiffness is a systemic loss of elastic properties that significantly augment cardiovascular disease risk in adults. Chronic aerobic and anaerobic exercise activity has consistently been shown to attenuate or not affect markers of arterial stiffness in adults with chronic disease and otherwise healthy adults. Chronic high functional resistance training's effect on vascular compliance is less understood. The study aimed to determine the impact of a chronic high functional resistance training program on pulse wave velocity and beta-stiffness index. Accordingly, participants (18-40 years old) were placed in a non-randomized fashion into high functional resistance training (HIB) group (n = 9; >6 months of CrossFit experience; 4 female) or control (CON) group (n = 8; \< 6 months of exercise experience; 6 female). Participants in the HIB group trained at the same local facility 4 -5 days a week, utilizing the same training program. CON group refrained from exercise during the study period. Body composition, 1,000-meter rowing test, deadlift 1 repetition maximum (1 RM), hemodynamic assessments, and vascular compliance were assessed at baseline and follow-up.

02

Conditions studied

  • Training Study

Keywords

  • pulse wave velocity
  • beta-stiffness index
  • central arterial blood pressure
  • CrossFit training
03

In context

Lead sponsor

Salisbury University is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • body weight stability with no more than ± 2.5 kg fluctuations in last six month

Exclusion criteria

Exclusion Criteria:

  • hypertension
  • heart disease
  • cancer
  • diabetes
  • renal disease
  • hepatic disorders
  • history of tobacco use.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    Exercise Group

    Other: Exercise

  • Placebo comparator
    Control Group

    Other: Control

Interventions

  • OtherExercise

    The exercise group performed an 11-week high-functional resistance program in a group training format. They trained 3-4 days a week following nationally assigned workouts

  • OtherControl

    Did not participate in exercise related activities for the duration of the study period.

06

What researchers measure

Primary outcomes

  1. Pulse wave velocity

    Time frame: From enrollment to the end of treatment at 11 weeks

07

Study locations

1 site
  • Salisbury University
    Salisbury, Maryland 21801, United States
08

References and documents

Publications

  • Garcia-Mateo P, Garcia-de-Alcaraz A, Rodriguez-Perez MA, Alcaraz-Ibanez M. Effects of Resistance Training on Arterial Stiffness in Healthy People: A Systematic Review. J Sports Sci Med. 2020 Aug 13;19(3):444-451. eCollection 2020 Sep. PubMed 32874096 ↗

Individual participant data

Plan to share: Yes — Data will be shared upon request.

Supporting information: Study protocol, Sap, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06935318
Lead sponsor
Salisbury University
Responsible party
Timothy Werner (Professor, Salisbury University) — Principal investigator
First posted
Apr 20, 2025
Start date
Aug 29, 2020
Primary completion
Dec 10, 2023
Completion
Jan 15, 2024
Last update
Apr 20, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion